Paper39227809
Dihydromyricetin suppresses endothelial NLRP3 inflammasome activation and attenuates atherogenesis by promoting mitophagy.
Hu Q and 9 others. Lipids Health Dis, 2024. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Dihydromyricetin suppresses endothelial NLRP3 inflammasome activation and attenuates atherogenesis by promoting mitophagy. Papers, record 39227809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39227809
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dihydromyricetin suppresses endothelial NLRP3 inflammasome activation and attenuates atherogenesis by promoting mitophagy.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| NLR Family, Pyrin Domain-Containing 3 Protein | Major topic |
| Mitophagy | Major topic |
| Flavonols | Major topic |
| Atherosclerosis | Major topic |
| Inflammasomes | Major topic |
| Human Umbilical Vein Endothelial Cells | Major topic |
| Diet, High-Fat | Major topic |
| Animals | |
| Mice | |
| Humans | |
| Male | |
| Mice, Inbred C57BL | |
| Interleukin-1beta | |
| Mitochondria |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 81803229 | National Natural Science Foundation of China | PubMed | ||
| cstc2020jcyj-msxmX0105 | Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission | PubMed |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22258606 | Inflammasomes in health and disease. | Nature | 2012 | https://conductscience.org/library/papers/22258606 | PubMed |
| 2 | 29310441 | Dihydromyricetin Ameliorates Nonalcoholic Fatty Liver Disease by Improving Mitochondrial Respiratory Capacity and Redox Homeostasis Through Modulation of SIRT3 Signaling. | Antioxid Redox Signal | 2019 | https://conductscience.org/library/papers/29310441 | PubMed |
| 3 | 29256638 | Mitochondria, the NLRP3 Inflammasome, and Sirtuins in Type 2 Diabetes: New Therapeutic Targets. | Antioxid Redox Signal | 2018 | https://conductscience.org/library/papers/29256638 | PubMed |
| 4 | 28500865 | Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice. | Atherosclerosis | 2017 | https://conductscience.org/library/papers/28500865 | PubMed |
| 5 | 31036962 | The NLRP3 inflammasome: molecular activation and regulation to therapeutics. | Nat Rev Immunol | 2019 | https://conductscience.org/library/papers/31036962 | PubMed |
| 6 | 33336364 | Physicochemical properties of dihydromyricetin and the effects of ascorbic acid on its stability and bioavailability. | J Sci Food Agric | 2021 | https://conductscience.org/library/papers/33336364 | PubMed |
| 7 | 23525089 | Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection. | Nat Immunol | 2013 | https://conductscience.org/library/papers/23525089 | PubMed |
| 8 | 819830 | The pathogenesis of atherosclerosis (first of two parts). | N Engl J Med | 1976 | https://conductscience.org/library/papers/819830 | PubMed |
| 9 | 30254716 | Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition. | Oxid Med Cell Longev | 2018 | https://conductscience.org/library/papers/30254716 | PubMed |
| 10 | 26919428 | NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria. | Cell | 2016 | https://conductscience.org/library/papers/26919428 | PubMed |
| 11 | 21732177 | IL-6 induces lipolysis and mitochondrial dysfunction, but does not affect insulin-mediated glucose transport in 3T3-L1 adipocytes. | J Bioenerg Biomembr | 2011 | https://conductscience.org/library/papers/21732177 | PubMed |
| 12 | 25797177 | Dihydromyricetin improves skeletal muscle insulin resistance by inducing autophagy via the AMPK signaling pathway. | Mol Cell Endocrinol | 2015 | https://conductscience.org/library/papers/25797177 | PubMed |
| 13 | 30046112 | New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. | Nature | 2018 | https://conductscience.org/library/papers/30046112 | PubMed |
| 14 | 3426656 | Quantitative assessment of atherosclerotic lesions in mice. | Atherosclerosis | 1987 | https://conductscience.org/library/papers/3426656 | PubMed |
| 15 | 33917744 | Endothelial Dysfunction, Inflammation and Coronary Artery Disease: Potential Biomarkers and Promising Therapeutical Approaches. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33917744 | PubMed |
| 16 | 32301289 | Dihydromyricetin increases endothelial nitric oxide production and inhibits atherosclerosis through microRNA-21 in apolipoprotein E-deficient mice. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/32301289 | PubMed |
| 17 | 18599066 | Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. | Atherosclerosis | 2009 | https://conductscience.org/library/papers/18599066 | PubMed |
| 18 | 27907038 | Equol Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice by Inhibiting Endoplasmic Reticulum Stress via Activation of Nrf2 in Endothelial Cells. | PLoS One | 2016 | https://conductscience.org/library/papers/27907038 | PubMed |
| 19 | 35115939 | Mechanism of Dihydromyricetin on Inflammatory Diseases. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/35115939 | PubMed |
| 20 | 25202020 | Xenobiotic pregnane X receptor (PXR) regulates innate immunity via activation of NLRP3 inflammasome in vascular endothelial cells. | J Biol Chem | 2014 | https://conductscience.org/library/papers/25202020 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42678662 | Empagliflozin Improves Atherosclerosis by Promoting Mitophagy in Endothelial Cells. | Cardiovasc Drugs Ther | 2026 | https://conductscience.org/library/papers/42678662 | PubMed |
| 42507233 | Molecular biology of vascular bioenergetics rewiring: Mitochondrial protective mechanisms of Piper retrofractum in hypertension and oxidative injury. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42507233 | PubMed |
| 42421923 | Functional sweet tea in China: species, sweet components and anti-metabolic disease effects. | Front Nutr | 2026 | https://conductscience.org/library/papers/42421923 | PubMed |
| 42387586 | Exploring the role of the NLRP3 Inflammasome in polycystic ovary syndrome: therapeutic potential of herbal medicines. | J Ovarian Res | 2026 | https://conductscience.org/library/papers/42387586 | PubMed |
| 42272829 | Multi-target mechanisms and therapeutic potential of Dahuang Zhechong pill in lower extremity peripheral artery disease: a structured narrative review. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42272829 | PubMed |
| 42196602 | Mechanistic Insights into Dihydromyricetin: Redox Modulation and Kinase-Mediated Control of Disease Pathogenesis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196602 | PubMed |
| 42131331 | sEH inhibition attenuates mtROS-mediated NLRP3 inflammasome activation by promoting mitophagy in tubular epithelial cells in diabetic kidney disease. | Front Immunol | 2026 | https://conductscience.org/library/papers/42131331 | PubMed |
| 42074289 | Targeting the NLRP3 Inflammasome in Atherosclerosis: A Review of Natural Products and Their Molecular Mechanisms. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074289 | PubMed |
| 42049985 | Mechanistic insights into natural product-driven modulation of NLRP3-inflammasome signalling in metabolic syndrome. | Inflamm Res | 2026 | https://conductscience.org/library/papers/42049985 | PubMed |
| 42022551 | Food-derived dihydromyricetin and metabolic dysfunction-associated steatotic liver disease: a preclinical systematic review and meta-analysis. | Front Nutr | 2026 | https://conductscience.org/library/papers/42022551 | PubMed |
| 41642401 | Enhancing Mitophagy with PEP-1-CAT Attenuates Vascular Inflammation and Atherogenesis in Mice. | Inflammation | 2026 | https://conductscience.org/library/papers/41642401 | PubMed |
| 41596522 | Luteolin Enhances Endothelial Barrier Function and Attenuates Myocardial Ischemia-Reperfusion Injury via FOXP1-NLRP3 Pathway. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596522 | PubMed |
| 41518391 | Cross-regulation of autophagy and pyroptosis: a new perspective on the inflammatory microenvironment of atherosclerosis. | Apoptosis | 2026 | https://conductscience.org/library/papers/41518391 | PubMed |
| 41146344 | MiR-24-3p delivered by adipose derived stem cells exosomes alleviate macrophage pyroptosis via NLRP3/Caspase1/GSDMD in sepsis ALI. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/41146344 | PubMed |
| 40786081 | Bibliometric analysis of research hotspots and emerging trends in mitophagy and atherosclerosis (2004-2024). | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40786081 | PubMed |
| 40632327 | A narrative review on bridging the gap between periodontitis and cardiovascular disease: exploring the cellular and molecular mechanisms of periodontitis-driven atherosclerosis. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/40632327 | PubMed |
| 39951122 | Dihydromyricetin alleviates imiquimod-induced psoriasiform inflammation by inhibiting M1 macrophage polarization. | Arch Dermatol Res | 2025 | https://conductscience.org/library/papers/39951122 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APOE | 348 | PubTator's text mining | https://conductscience.org/library/genes/348 | NCBI Gene |
| IL1B | 3553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| NLRP3 | 114548 | PubTator's text mining | https://conductscience.org/library/genes/114548 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39227809
GET https://conductscience.org/api/papers/v1/39227809/references?page=2